Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Redbaron2211on Mar 21, 2021 8:23pm
235 Views
Post# 32848012

RE:RE:RE:RE:Today's Trading

RE:RE:RE:RE:Today's Trading

DF I'm not privy to any material information.  I have as you inferred been through enough rodeos to know Sernova's board talks with institutional investors started long before the breakout.  I'm currently closely following 2 companies that just did a bought deal and through some deductive reasoning was able build up enough confidence to point that out publicly.  Anyways I could see how it might be suspicious but that hypothesis is not valid in my case anyways.  


 
Another thing I was going to comment on was from my understanding the 15% over allotment was likely used as a Greenshoe option where Canaccord would have shorted this to amount to "stabilize" the price by shorting the overallotment (or 'greenshoe') options.  From my understanding this is all legal and common practice especially with IPOs.    As for my absence, I was just out on a ski trip this week catching up now.  
<< Previous
Bullboard Posts
Next >>